Spacers are used by people with respiratory diseases who have problems using MDIs (metered
dose inhalers). This study used fluticasone propionate/salmeterol to look at the
pharmacokinetic profiles produced by different spacers in their washed and un-washed states.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Salmeterol Xinafoate Xhance